Exchange: NASDAQ·Updated 05:45 AM EDT
TPST logo

TPST Tempest Therapeutics Inc

$1.11
$0.01
(0.91%)
Pre-Market
Prev Close $1.10
Reported EarningsAug 13
Mkt Cap$16.78M
Vol16,081.00

About TPST

Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients. Tempest Therapeutics was founded in 2011 and is headquartered in Brisbane, CA.
49

Neutral Sentiment

How do you feel about TPST?

Advertisement|Remove ads.